ORLANDO – The Generic Pharmaceutical Association struck a combative tone at the start of its annual meeting, calling out two companies pushing legislation in states that could potentially limit biosimilar use, including one with a representative at the event.
GPhA President and CEO Ralph Neas used his Feb. 21 speech at the meeting to scold Amgen Inc. and Genentech Inc
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?